Emblem Corp To Disrupt $60 Billion Opiod Market With Cannabis Based Sustained Release Formulation

TSXV: EMC

Very big news out of Emblem Corp $EMC.V today, with the halt on this news event lifted tomorrow morning at 5AM PST Oct 4th... This is one to watch: Emblem Announces Exclusive Agreement with Canntab Therapeutics for Cannabinoid Based Oral Sustained Release Formulation PARIS, Ontario, Oct. 03, 2017 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (EMC.WT) (“Emblem” or the "Company") announced today that it has entered into a Collaboration and Licensing Agreement (the “Agreement”) with Canntab … [Read more...]